Picture Kentro Design Is Key to Your Success Berlin 650x100px
Organisation › Details

Promise Proteomics SAS

PX'Therapeutics is a biopharmaceutical contract research and manufacturing organisation specialising in the development of therapeutic antibodies and recombinant proteins from early research stage up to clinical grade GMP manufacturing. With more than 160 clients in Europe, North America and Japan, PX'Therapeutics has acquired an extensive knowledge in the production of valuable therapeutic candidates. *


Period Start 2019-07-01 renamed
  Group Aguettant (Group)
  Predecessor PX’Therapeutics S.A.
Product Industry contract manufacturing (biologicals)
Persons Person Rougemond, Eric (Aguettant 201302– CEO)
  Person 2 Rousselle, Tristan (Protein’eXpert 200011–201306 CEO + Co-Founder LEFT 6/13 before Genome Express)
Region Region Grenoble
  Country France
  Street 7 parvis Louis Néel
BHT 52 A, CS 20050
  City 38040 Grenoble cedex 9
  Tel +33-4-3802-3650
    Address record changed: 2020-12-02
Basic data Employees B: 11 to 50 (2012-10-01)
  Currency EUR
  Annual sales 8,500,000 (revenues (2011) 2011-12-31)
    * Document for »About Section«: 
Record changed: 2024-03-30


Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

More documents for Aguettant (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group World of Partnering Opportunities 650x300px

» top